Scarica l'app Stockscreener
9.87
0.64%
0.075
Liquidia Corp Borsa (LQDA) Ultime notizie
There is no doubt that Liquidia Corp (LQDA) ticks all the boxes. - SETE News
Quarterly Snapshot: Quick and Current Ratios for Liquidia Corp (LQDA) - The Dwinnex
Liquidia Co. (NASDAQ:LQDA) Position Reduced by Principal Financial Group Inc. - Defense World
Latham & Watkins Advised on Liquidia Corporation’s Common Stock Financing - Legal Desire News Network
Liquidia Corp [LQDA] Records 200-Day SMA of $12.32 - Knox Daily
Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock? - Yahoo Finance
Liquidia secures $100 million for cardiopulmonary drug development - Investing.com
LQDA’s Market Whiplash: -17.21% YTD Decline, -18.43% Plunge in 30 Days - The InvestChronicle
Liquidia (NASDAQ:LQDA) Shares Gap Up to $8.90 - MarketBeat
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement - Yahoo Finance
Investing in Liquidia Corp (LQDA) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Liquidia Corp (LQDA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Take off with Liquidia Corp (LQDA): Get ready for trading - SETE News
Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Liquidia surges after sealed document as investors await FDA Yutrepia decision - MSN
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings - Business Wire
Liquidia Corp (LQDA)’s Day in Review: Closing at 8.94, Down by -1.76 - The Dwinnex
Liquidia Corp CFO sells over $10k in company stock By Investing.com - Investing.com Australia
Liquidia Corp executive sells over $5,000 in company stock By Investing.com - Investing.com Australia
Liquidia Corp executive sells over $4,300 in company stock By Investing.com - Investing.com Australia
Ready to Jump After Recent Trade: Liquidia Corp (LQDA) - SETE News
Michael Kaseta Sells 1,079 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia Corp executive sells over $4,300 in company stock - Investing.com
Liquidia Corp executive sells over $4,300 in company stock - Investing.com India
Liquidia Corp executive sells over $5,000 in company stock - Investing.com India
Liquidia Corp CFO sells over $10k in company stock - Investing.com India
Liquidia Corp CFO sells over $10k in company stock By Investing.com - Investing.com Canada
Liquidia Corp executive sells over $4,300 in company stock By Investing.com - Investing.com Canada
Liquidia Corp executive sells over $4,300 in company stock By Investing.com - Investing.com UK
Liquidia Corp executive sells over $5,000 in company stock By Investing.com - Investing.com UK
2024-09-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc.(LQDA) and Encourages Investors to Learn More About the Investigation | NDAQ:LQDA | Press Release - Stockhouse Publishing
Fed. Circ. Mulls PTAB Ruling's Effect On Liquidia Drug Launch - Law360
2024-09-03 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Liquidia Technologies, Inc.(LQDA) And Encourages Investors to Reach Out | NDAQ:LQDA | Press Release - Stockhouse Publishing
LQDA underperforms with a -0.31 decrease in share price - US Post News
Liquidia Corp [LQDA] Records 200-Day SMA of $12.21 - Knox Daily
Liquidia to Present at Upcoming Investor Conferences - Yahoo Finance
LQDA underperforms with a -1.40 decrease in share price - US Post News
Market Insights: Liquidia Corp (LQDA)’s Notable Drop of -1.40, Closing at 9.83 - The Dwinnex
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - PR Newswire
Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’ - Insider Monkey
Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’ - Yahoo Finance
Liquidia Corp (LQDA) can make a big difference with a little luck - SETE News
Liquidia Corp [LQDA] Shares Jump Approximately 46.76% Over the Year - Knox Daily
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session - MSN
Q3 2024 Earnings Estimate for Liquidia Co. Issued By HC Wainwright (NASDAQ:LQDA) - MarketBeat
Liquidia challenges regulatory exclusivity for rival's inhaled drug - Reuters
HC Wainwright Comments on Liquidia Co.’s Q3 2024 Earnings (NASDAQ:LQDA) - Defense World
Liquidia contests FDA decision on drug exclusivity - Investing.com
Liquidia challenges regulatory exclusivity for rival's inhaled drug - ETHealthWorld
Liquidia down after co challenges regulatory exclusivity for rival's inhaled drug - XM
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD - Yahoo Finance
FDA grants tentative approval of Yutrepia - The Pharma Letter
Liquidia (NASDAQ:LQDA) vs. Adagene (NASDAQ:ADAG) Critical Contrast - Defense World
Liquidia (NASDAQ:LQDA) Sees Large Volume Increase - MarketBeat
Liquidia Corp [LQDA] is -18.62% lower this YTD. Is it still time to buy? - The DBT News
BofA cuts Liquidia Technologies stock target price, maintains Buy target - Investing.com
Liquidia (NASDAQ:LQDA) Price Target Cut to $23.00 by Analysts at Bank of America - MarketBeat
Liquidia Technologies stock target cut by H.C. Wainwright - Investing.com
How will Liquidia Corp’s (LQDA) earnings compare to estimates this quarter? - US Post News
Liquidia's inhaled drug fails to get traditional approval in US, shares fall - MSN
Liquidia's Yutrepia Delay: The Clock Is Ticking On Financial Viability (Rating Downgrade) - Seeking Alpha
Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia - Yahoo Finance
These Analysts Cut Their Forecasts On Liquidia - Benzinga
HC Wainwright Cuts Liquidia (NASDAQ:LQDA) Price Target to $29.00 - Defense World
Liquidia secures FDA tentative approval for Yutrepia inhalation powder - World Pharmaceutical Frontiers
Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval - Pharmaceutical Technology
Liquidia (NASDAQ:LQDA) Price Target Lowered to $25.00 at BTIG Research - Defense World
Liquidia (NASDAQ:LQDA) Upgraded to Strong-Buy at Raymond James - Defense World
1.25%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):